Rabigen SAG2 (--) - Oral suspension
Rabigen SAG2 (--) - Oral suspension
Authorised
- Rabies virus, strain SAG2, Live
Product identification
Medicine name:
Rabigen SAG2 (--) - Oral suspension
Active substance:
- Rabies virus, strain SAG2, Live
Target species:
-
Fox
-
Raccoon dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rabies virus, strain SAG2, LivePresentation_strength:0.18 ml Reference:Hse Comments:IN SACHET- Isotonic saline solution containing a minimum of 8 log10 CCID50 (Cell Culture Infective Dose 50 %) / dose. SAG2 strain. Index:0
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
- Fox
- Raccoon dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BD
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Package description:
- Packaging:PVC/aluminium sachets embedded in a bait matrix, Package_size:400 bait
- Packaging:PVC/aluminium sachets embedded in a bait matrix, Package_size:200 bait
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
- Virbac S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 21/11/2022
Bulgarian (PDF)
Published on: 21/11/2022
Croatian (PDF)
Published on: 21/11/2022
Czech (PDF)
Published on: 21/11/2022
Danish (PDF)
Published on: 21/11/2022
Dutch (PDF)
Published on: 21/11/2022
Estonian (PDF)
Published on: 21/11/2022
Finnish (PDF)
Published on: 21/11/2022
French (PDF)
Published on: 21/11/2022
German (PDF)
Published on: 21/11/2022
Greek (PDF)
Published on: 21/11/2022
Hungarian (PDF)
Published on: 21/11/2022
Icelandic (PDF)
Published on: 21/11/2022
Italian (PDF)
Published on: 21/11/2022
Latvian (PDF)
Published on: 21/11/2022
Lithuanian (PDF)
Published on: 21/11/2022
Maltese (PDF)
Published on: 21/11/2022
Norwegian (PDF)
Published on: 21/11/2022
Polish (PDF)
Published on: 21/11/2022
Portuguese (PDF)
Published on: 21/11/2022
Romanian (PDF)
Published on: 21/11/2022
Slovak (PDF)
Published on: 21/11/2022
Slovenian (PDF)
Published on: 21/11/2022
Spanish (PDF)
Published on: 21/11/2022
Swedish (PDF)
Published on: 21/11/2022
How useful was this page?:
